iA Global Asset Management Inc. bought a new position in STERIS plc (NYSE:STE – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 7,624 shares of the medical equipment provider’s stock, valued at approximately $1,933,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Board of the Pension Protection Fund purchased a new position in STERIS in the fourth quarter worth $25,000. Activest Wealth Management boosted its position in STERIS by 423.8% during the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 89 shares during the period. Harbor Investment Advisory LLC boosted its position in STERIS by 115.4% during the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 60 shares during the period. Cornerstone Planning Group LLC boosted its position in STERIS by 342.3% during the fourth quarter. Cornerstone Planning Group LLC now owns 115 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 89 shares during the period. Finally, Cloud Capital Management LLC purchased a new stake in STERIS during the third quarter valued at about $29,000. 94.69% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at STERIS
In related news, Director Cynthia L. Feldmann sold 3,098 shares of the stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the transaction, the director directly owned 705 shares of the company’s stock, valued at $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.07% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on STE
STERIS Stock Performance
Shares of NYSE:STE opened at $213.22 on Tuesday. The company has a market cap of $20.91 billion, a price-to-earnings ratio of 26.89 and a beta of 0.95. The company has a 50-day moving average price of $219.13 and a 200-day moving average price of $242.72. The company has a current ratio of 2.09, a quick ratio of 1.54 and a debt-to-equity ratio of 0.25. STERIS plc has a 12 month low of $195.14 and a 12 month high of $269.44.
STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing the consensus estimate of $2.86 by ($0.03). The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the company posted $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, equities analysts anticipate that STERIS plc will post 11.18 EPS for the current year.
STERIS Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 8th will be paid a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Monday, June 8th. STERIS’s dividend payout ratio is presently 31.78%.
STERIS Profile
STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.
Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.
Featured Stories
- Five stocks we like better than STERIS
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
